Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4664309

C[C@@](N)(C(N)=O)C(=O)c1cccnc1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
F7 P08709 1/20 0.49
F3 P13726 1/20 0.49
SARM1 Q6SZW1 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
SIRT6 Q8N6T7 1/20 0.49
SIRT1 Q96EB6 1/20 0.49
SIRT3 Q9NTG7 1/20 0.49
SIRT5 Q9NXA8 1/20 0.49
SIRT4 Q9Y6E7 1/20 0.49
PLOD2 O00469 2/20 0.47
PLOD3 O60568 1/20 0.47
PLOD1 Q02809 1/20 0.47
ALDH1A1 P00352 4/20 0.46
APP P05067 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5650237 0.91 LMNA (0.59) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL5650240 0.91 LMNA (0.59) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL4665150 0.91 LMNA (0.59) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL4666411 0.90 LMNA (0.58) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL4666408 0.90 LMNA (0.58) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL4665099 0.90 LMNA (0.58) LMNACYP1A2CYP3A4CYP11B1CYP11B2
SCHEMBL27576450 0.87 LMNA (0.61) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Trifluoroacetic Acid SCHEMBL4666829 0.82 PLOD2 (0.41) LMNACYP1A2CYP3A4PLOD2PLOD3
Niacinamide SCHEMBL30011021 0.81 F7 (0.76) LMNACYP1A2CYP3A4CYP11B1CYP11B2
Niacinamide SCHEMBL28262350 0.81 F7 (0.76) LMNACYP1A2CYP3A4CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299263-A1 Hydroxy Alkyl Amines Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company 2007-12-27 US claimed
US-7144897-B2 Hydroxy alkyl amines Elan Oharmaceuticals, Inc. (US) 2006-12-05 US claimed
US-20030166717-A1 Hydroxy alkyl amines FRESKOS JOHN (US) 2003-09-04 US claimed
EP-1395551-B1 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES ELAN PHARM INC (US) 2008-05-21 EP disclosed
US-20070299263-A1 Hydroxy Alkyl Amines Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company 2007-12-27 US disclosed
US-7144897-B2 Hydroxy alkyl amines Elan Oharmaceuticals, Inc. (US) 2006-12-05 US disclosed
US-20030166717-A1 Hydroxy alkyl amines FRESKOS JOHN (US) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166717-A1 Hydroxy alkyl amines PSEN1, MAOA, PSEN2 LMNA 549/4885CYP1A2 161/4885CYP3A4 879/4885
US-20070299263-A1 Hydroxy Alkyl Amines MAOA, PSEN2, PSEN1 LMNA 507/4885CYP1A2 207/4885CYP3A4 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.